This upregulation appears to shield HCC cells from the anti-proliferative effects of ActA, highlighting it as a potential mechanism promoting tumor progression and a possible target for therapeutic intervention (Frost et al., 2011). This evidence concerns the gene ACTA1 and hepatocellular carcinoma.